Literature DB >> 31585496

Influence of Antagonistic Hamstring Coactivation on Measurement of Quadriceps Strength in Older Adults.

Jason-Flor Sisante1, Na Wang2, David T Felson2, Michael C Nevitt3, Cora E Lewis4, Laura Frey-Law5, Neil A Segal1,6.   

Abstract

BACKGROUND: There is limited understanding of how antagonist muscle coactivation relates to measurement of strength in both individuals with and without knee osteoarthritis (KOA).
OBJECTIVE: This study sought to determine whether hamstring coactivation during a maximal quadriceps activation task attenuates net quadriceps strength.
DESIGN: Cross-sectional cohort analysis was conducted using data from the 60-month visit of the Multicenter Osteoarthritis Study (MOST).
SETTING: Laboratory. PARTICIPANTS: A sample of 2328 community-dwelling MOST participants between the ages of 55 and 84 years, with or at elevated risk for KOA, completed the 60-month MOST follow-up visit. Of these, 1666 met inclusion criteria for the current study.
INTERVENTIONS: Not applicable. MAIN OUTCOME MEASURE(S): Quadriceps strength; percentage of combined hamstring coactivation (HC), medial HC, and lateral HC. Quadriceps and hamstring strength were assessed using an isokinetic dynamometer. Surface electromyography was used to assess muscle activation patterns. General linear models, adjusted for age, BMI, Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), Kellgren-Lawrence (KL) grade and study site, modeled the relationship between antagonist hamstring coactivation and quadriceps strength.
RESULTS: Men had significantly greater quadriceps strength (P < .001), history of knee injury (P < .001) and surgery (P = .002), and greater presence of varus malalignment (P < .001). Women had greater pain (P < .001) and proportion of KL grade ≥2 (P = .017). Gender-specific analyses revealed combined HC (P = .013) and lateral HC inversely associated with quadriceps strength in women (P = .023) but not in men (combined HC P = .320, lateral HC P = .755). A nonlinear association was detected between quadriceps strength and medial HC. Assessment of quartiles of medial HC revealed the third quartile had reduced quadriceps strength when compared to the lowest quartile of coactivation in both men and women.
CONCLUSIONS: Hamstring coactivation attenuates measured quadriceps strength in women with or at elevated risk for KOA. LEVEL OF EVIDENCE: II.
© 2019 American Academy of Physical Medicine and Rehabilitation.

Entities:  

Mesh:

Year:  2019        PMID: 31585496      PMCID: PMC8016551          DOI: 10.1002/pmrj.12253

Source DB:  PubMed          Journal:  PM R        ISSN: 1934-1482            Impact factor:   2.298


  48 in total

1.  Effects of strength training on the incidence and progression of knee osteoarthritis.

Authors:  Alan E Mikesky; Steven A Mazzuca; Kenneth D Brandt; Susan M Perkins; Teresa Damush; Kathleen A Lane
Journal:  Arthritis Rheum       Date:  2006-10-15

2.  Gait and neuromuscular pattern changes are associated with differences in knee osteoarthritis severity levels.

Authors:  Janie L Astephen; Kevin J Deluzio; Graham E Caldwell; Michael J Dunbar; Cheryl L Hubley-Kozey
Journal:  J Biomech       Date:  2008-02-20       Impact factor: 2.712

3.  Knee extension and flexion weakness in people with knee osteoarthritis: is antagonist cocontraction a factor?

Authors:  Tamika L Heiden; David G Lloyd; Timothy R Ackland
Journal:  J Orthop Sports Phys Ther       Date:  2009-11       Impact factor: 4.751

4.  The Multicenter Osteoarthritis Study: opportunities for rehabilitation research.

Authors:  Neil A Segal; Michael C Nevitt; K Douglas Gross; Keith D Gross; Jean Hietpas; Natalie A Glass; Cora E Lewis; James C Torner
Journal:  PM R       Date:  2013-08       Impact factor: 2.298

5.  Defining radiographic incidence and progression of knee osteoarthritis: suggested modifications of the Kellgren and Lawrence scale.

Authors:  David T Felson; Jingbo Niu; Ali Guermazi; Burton Sack; Piran Aliabadi
Journal:  Ann Rheum Dis       Date:  2011-09-08       Impact factor: 19.103

6.  Muscular coactivation. The role of the antagonist musculature in maintaining knee stability.

Authors:  R Baratta; M Solomonow; B H Zhou; D Letson; R Chuinard; R D'Ambrosia
Journal:  Am J Sports Med       Date:  1988 Mar-Apr       Impact factor: 6.202

7.  Increased duration of co-contraction of medial knee muscles is associated with greater progression of knee osteoarthritis.

Authors:  Paul W Hodges; Wolbert van den Hoorn; Tim V Wrigley; Rana S Hinman; Kelly-Ann Bowles; Flavia Cicuttini; Yuanyuan Wang; Kim Bennell
Journal:  Man Ther       Date:  2015-07-17

Review 8.  Joint mechanics in osteoarthritis.

Authors:  Walter Herzog; Andrea Clark; David Longino
Journal:  Novartis Found Symp       Date:  2004

9.  The longitudinal relationship between thigh muscle mass and the development of knee osteoarthritis.

Authors:  N A Segal; C Findlay; K Wang; J C Torner; M C Nevitt
Journal:  Osteoarthritis Cartilage       Date:  2012-09-03       Impact factor: 6.576

10.  Sex differences in human adipose tissues - the biology of pear shape.

Authors:  Kalypso Karastergiou; Steven R Smith; Andrew S Greenberg; Susan K Fried
Journal:  Biol Sex Differ       Date:  2012-05-31       Impact factor: 5.027

View more
  3 in total

1.  Association between hamstring coactivation during isokinetic quadriceps strength testing and knee cartilage worsening over 24 months.

Authors:  M T Murphy; N Wang; D T Felson; M C Nevitt; C E Lewis; L Frey-Law; A Guermazi; N A Segal
Journal:  Osteoarthritis Cartilage       Date:  2022-03-18       Impact factor: 7.507

2.  Gastrocnemius Muscle Injury Is the Condition to Induce Cartilage Degeneration of the Rabbit Tibiofemoral Joint: A New Perspective.

Authors:  Yuanyuan Li; Jiwei Sun; Yimin Hou; Jiabi Wei; Yuzhuo Chai; Xiangyu Zhu; Rongguo Wang
Journal:  Biomed Res Int       Date:  2022-09-02       Impact factor: 3.246

3.  Interaction between age and fatigue on antagonist muscle coactivation during an acute post-fatigue recovery phase.

Authors:  Sara A Harper; Brennan J Thompson
Journal:  Front Aging       Date:  2022-10-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.